Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10638007 | 1.00 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL1159661 | 0.86 | — | — | |
| SCHEMBL3509878 | 0.83 | — | — | |
| SCHEMBL2631621 | 0.83 | — | — | |
| SCHEMBL10017792 | 0.83 | — | — | |
| SCHEMBL14087093 | 0.83 | — | — | |
| SCHEMBL10071984 | 0.83 | — | — | |
| SCHEMBL23282569 | 0.82 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL10045773 | 0.78 | — | — | |
| Isopropyl Alcohol SCHEMBL28543410 | 0.75 | ALDH1A1 (0.46) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4077466-B1 | METHOD FOR PRODUCING AN AROMATIC DIETHER AND CORRESPONDING METHODS FOR PRODUCING POLYARYLETHERKETONES | ARKEMA FRANCE (FR) | 2023-12-20 | — | — | EP | claimed |
| EP-3720920-A1 | IONIC LIQUID BASED WELL ASPHALTENE INHIBITORS AND METHODS OF USING THE SAME | Baker Hughes Holdings LLC (US) | 2020-10-14 | — | — | EP | claimed |
| WO-2019113513-A1 | IONIC LIQUID BASED WELL ASPHALTENE INHIBITORS AND METHODS OF USING THE SAME | BAKER HUGHES, A GE COMPANY, LLC (US) | 2019-06-13 | — | — | WO | claimed |
| WO-2024074641-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2024-04-11 | — | — | WO | disclosed |
| EP-3720920-B1 | IONIC LIQUID BASED WELL ASPHALTENE INHIBITORS AND METHODS OF USING THE SAME | BAKER HUGHES HOLDINGS LLC (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20230097436-A1 | Method For Producing An Aromatic Diether And Corresponding Methods For Producing Polyaryl Ether Ketones | ARKEMA FRANCE (FR) | 2023-03-30 | — | — | US | disclosed |
| US-20220169929-A1 | Methods of Using Ionic Liquids as Demulsifiers | BAKER HUGHES HOLDINGS LLC | 2022-06-02 | — | — | US | disclosed |
| US-20220098494-A1 | METHODS OF USING IONIC LIQUIDS AS CORROSION INHIBITORS | BAKER HUGHES HOLDINGS LLC | 2022-03-31 | — | — | US | disclosed |
| US-20220056345-A1 | IONIC LIQUIDS AND METHODS OF USING SAME | BAKER HUGHES HOLDINGS LLC | 2022-02-24 | — | — | US | disclosed |
| US-11254881-B2 | Methods of using ionic liquids as demulsifiers | BAKER HUGHES HOLDINGS LLC (US) | 2022-02-22 | — | — | US | disclosed |
| US-11124692-B2 | Methods of using ionic liquid based asphaltene inhibitors | BAKER HUGHES HOLDINGS LLC (US) | 2021-09-21 | — | — | US | disclosed |
| EP-3720920-A1 | IONIC LIQUID BASED WELL ASPHALTENE INHIBITORS AND METHODS OF USING THE SAME | Baker Hughes Holdings LLC (US) | 2020-10-14 | — | — | EP | disclosed |
| US-20200017790-A1 | METHODS OF USING IONIC LIQUIDS AS PARAFFIN INHIBITORS, POUR POINT DEPRESSANTS AND COLD FLOW IMPROVERS | BAKER HUGHES HOLDINGS LLC | 2020-01-16 | — | — | US | disclosed |
| US-20190177599-A1 | Ionic Liquid Based Well Asphaltene Inhibitors and Methods of Using the Same | BAKER HUGHES HOLDINGS LLC | 2019-06-13 | — | — | US | disclosed |
| WO-2019113513-A1 | IONIC LIQUID BASED WELL ASPHALTENE INHIBITORS AND METHODS OF USING THE SAME | BAKER HUGHES, A GE COMPANY, LLC (US) | 2019-06-13 | — | — | WO | disclosed |
| US-20110065926-A1 | METHOD OF PREPARING IONIC LIQUIDS | BASF SE (DE) | 2011-03-17 | — | — | US | disclosed |
| US-7858802-B2 | Method of preparing ionic liquids | BASF SE (DE) | 2010-12-28 | — | — | US | disclosed |
| US-20070142646-A1 | Method of preparing ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065926-A1 | METHOD OF PREPARING IONIC LIQUIDS | INPPL1, IP6K3, ARSA | ALDH1A1 4398/4885 |
| US-20070142646-A1 | Method of preparing ionic liquids | INPPL1, IP6K3, ARSA | ALDH1A1 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.